Cargando…
Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation
Background and Objectives: Condoliase, a chondroitin sulfate ABC endolyase, is a novel and minimally invasive chemonucleolytic drug for lumbar disc herniation. Despite the growing number of treatments for lumbar disc herniation, the predicting factors for poor outcomes following treatment remain unc...
Autores principales: | Takeuchi, Shu, Hanakita, Junya, Takahashi, Toshiyuki, Inoue, Tomoo, Minami, Manabu, Suda, Izumi, Nakamura, Sho, Kanematsu, Ryo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781337/ https://www.ncbi.nlm.nih.gov/pubmed/36557070 http://dx.doi.org/10.3390/medicina58121868 |
Ejemplares similares
-
Correction: Takeuchi et al. Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation. Medicina 2022, 58, 1868
por: Takeuchi, Shu, et al.
Publicado: (2023) -
Unrecognized dural tear during percutaneous endoscopic lumbar surgery confirmed with myelography
por: Takeuchi, Shu, et al.
Publicado: (2023) -
Efficacy and Safety of Condoliase Disc Administration as a New Treatment for Lumbar Disc Herniation
por: Inoue, Masahiro, et al.
Publicado: (2021) -
Multicenter Retrospective Analysis of Intradiscal Condoliase Injection Therapy for Lumbar Disc Herniation
por: Oshita, Yusuke, et al.
Publicado: (2022) -
Clinical Outcomes of Condoliase Injection Therapy for Lateral Lumbar Disc Herniation
por: Kagami, Yujiro, et al.
Publicado: (2023)